A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Treatment Modalities for Heart Failure with Preserved Ejection Fraction (HFpEF) - Current State of Evidence and Future Perspective
2015
Journal of Clinical & Experimental Cardiology
Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of patients with chronic heart failure and is associated with significant morbidity and mortality. To date, there are no approved therapies available for reducing mortality or hospitalizations for these patients. The failure to develop successful therapies for the management of HFpEF may be because of the poor understanding of the pathophysiology of HFpEF, inadequate standardization of the HFpEF diagnosis,
doi:10.4172/2155-9880.1000383
fatcat:j6idzgenh5chreejsxcxxiskuq